公开(公告)号：US20170112924A1

公开(公告)日：2017-04-27

申请号：US15348881

申请日：2016-11-10

Applicant: VARIATION BIOTECHNOLOGIES INC.

Inventor： Maura Ellen CAMPBELL

IPC: A61K39/39 ,  A61K39/112 ,  A61K9/00 ,  A61K39/145 ,  A61K39/29 ,  A61K39/21 ,  A61K39/02

CPC classification number: A61K39/39 ,  A61K9/0019 ,  A61K9/127 ,  A61K9/19 ,  A61K39/00 ,  A61K39/0275 ,  A61K39/099 ,  A61K39/107 ,  A61K39/12 ,  A61K39/145 ,  A61K39/21 ,  A61K39/29 ,  A61K39/292 ,  A61K2039/55555 ,  A61K2039/55572 ,  C07H13/04 ,  C07H13/06 ,  C07H15/12 ,  C12N2760/16034 ,  C12N2760/16134 ,  C12N2760/16234 ,  Y02A50/484

Abstract: In one aspect, the present disclosure provides compounds of formulae I and II. In another aspect, a compound of formula I or II is formulated into compositions with an antigen, optionally with a vesicle. In some embodiments, compositions are administered intramuscularly.